GAVI welcomes Biden move on vaccines, urges U.S. manufacturers to transfer know-how
The Peninsula
Geneva: The GAVI vaccine alliance on Thursday welcomed U.S. President Joe Biden's support for waiving intellectual property rights for COVID-19 vaccines and also urged Washington to help manufacturers transfer know-how to boost global production.
The Geneva-based group, which co-leads the COVAX dose-sharing programme with the World Health Organization (WHO), faces major supply constraints after India suspended vaccine exports due to its major COVID-19 epidemic. "We recognise also the significance of the (Biden) administration’s commitment to work towards increasing raw material production, which will have an immediate impact on alleviating current global supply constraints," it told Reuters in a statement.More Related News